Part 1: Autism and Health Issues Unpacked: Exploring the Intersection of Autism and Chronic Fatigue Syndrome

Written by Claire Eliza Sehinson, MS with Dr. Megan Anna Neff, PsyD. Originally posted on Neurodivergent Insights


Do you ever find yourself navigating the maze of persistent fatigue, mysterious GI issues, hormonal sensitivities, and sensory sensitivities, wondering if these are linked to autism, chronic fatigue, or something else? You're not alone. You're not alone. Many in the Autistic community, including Autistic physician Mel Houser, refer to these myriad health complexities accompanying an Autism diagnosis as "all the things."

In this article, we, two Autistic professionals—a psychologist and a functional medicine provider—aim to unravel the intricate connections between Autism and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and other health conditions. We bring our clinical expertise and personal experiences to this complex intersection, hoping to clarify and illuminate the parallels and unique challenges faced by individuals dealing with both conditions.

From the prevalence of chronic fatigue and burnout in the Autistic and ADHD communities to the interconnected co-occurrence in CFS/ME, we explore the shared vulnerabilities and the risk of diagnostic overshadowing. Ultimately, we seek to differentiate between autism and CFS/ME, understand their overlaps, and underscore the need for accurate support and interventions.

This content, resembling an encyclopedia entry, delves into a wide range of health-related topics, rich in complexities and nuances. Feel free to dive into specific sections that pique your interest or browse through for a general understanding of various themes. This approach allows you to tailor your reading experience to your needs, whether you're seeking detailed information or an overarching summary.

It’s a lot of information, so feel free to skim ahead to the relevant sections!

  • Autism Overview

    • Autistic Neurotype

    • PMDD

    • EF Challenges

    • Genetic Conditions

    • Autistic Burnout

    • ARFID

    • Alexithymia

    • Sensory Sensitivities

    • Language and Auditory Processing Differences

    • Distinct Autistic Brain Style

    • Present from Birth

  • Chronic Fatigue Syndrome Overview

    • Key Diagnostic Characteristics

    • Additional Characteristics

    • ME/CFS Variability

    • Current Understanding and Treatment

    • Diagnosis

    • Common Co-occurring Health Conditions

    • Chronic Fatigue Triggers

  • Overlapping Characteristics

    • Brain Fog

    • Post-Viral Infections

    • Immune Dysregulation

    • Chronic Infections

    • Sleep Issues

    • Mitrochondrial Dysfunction

    • IBS

    • Gut Inflammation

    • SIBO

    • Leaky Gut

    • Mast Cell Activation and Histamine Intolerance

    • Methylanation 

    • Hypermobility and Ehler's Danlos

    • Dysautonomia and POTS (Postural Orthostatic Tachycardia Syndrome)

    • Insufficient Vitamin D, Essential Fatty Acids (i.e. Omega-3&6) & Minerals

    • HPA Axis Dysfunction

    • Neuroinflammation

    • Low Vagal Tone

    • Food and Chemical Sensitivities

    • Pyroluria

    • EMF Sensitivities

    • Pain and Firbryomyalia 

Autism Overview

Autism: A Distinct Neurotype

Autism is a distinct neurotype, characterized by a distinct and sensitive nervous system. This distinctiveness can sometimes lead to confusion with nervous system disorders like CFS/ME, complex trauma, and other dysautonomias.

Characteristics of Autistic Individuals

Autistic people have a specific way of perceiving and interacting with the world. This includes direct communication, a highly sensitive nervous system, a tendency for monotropic attention, self-soothing through repetition and routine, and a communication style marked by authenticity, directness, and literal language use.

The following are several experiences and conditions that often occur within the constellation of autism: 

  • PMDD

  • Executive Functioning Differences

  • Genetic Conditions

  • Autistic Burnout

  • ARFID and Eating Disorder

  • Significant sensory processing diferences 

  • Alexithymia and interoception challenges

PMDD (Premenstrual Dysphoric Disorder)

PMDD is a severe form of premenstrual syndrome characterized by significant mood swings and physical symptoms. This condition is often due to a genetic cellular sensitivity to changes in estrogen and progesterone levels. Studies indicate varying prevalence rates of PMDD among Autistic AFAB individuals, ranging from 14.5% to 92%. This significant variance underscores the impact PMDD has on mental health in this population, including a heightened prevalence of suicidal thoughts and attempts (Citation: Groenman, 2022)).

Executive Functioning Differences

Executive functioning encompasses a group of cognitive skills crucial for planning, organizing, initiating tasks, managing time, and regulating behavior. Many Autistic people experience differences in these areas, significantly affecting our daily life. These differences are particularly challenging when navigating health contexts, managing medications, and maintaining medical regimens. Understanding these challenges is vital in grasping how autism impacts an individual's experience of other health conditions.

It's important to note that while individuals with CFS/ME may also face executive functioning challenges, these are typically due to the illness itself and not a baseline characteristic. In contrast, Autistic individuals often have inherent difficulties with executive functioning. These challenges may intensify during periods of Autistic burnout or when dealing with co-occurring conditions, but they are a fundamental part of their baseline experience.

Genetic Conditions

In addition to their neurotype, some Autistic individuals may have co-occurring genetic conditions, including Prader-Willi syndrome. This rare genetic disorder affects growth, metabolism, and behavior. Although Prader-Willi syndrome's prevalence is low in the general population, a significant overlap exists with autism. Research indicates that 12-26% of individuals with Prader-Willi syndrome also exhibit autistic traits (Bennett, 2015; Kong et al., 2020).

While most Autistic individuals do not have Prader-Willi syndrome or other specific genetic conditions, the occurrence of these conditions is higher among Autistic people compared to the non-autistic (allistic) population. Current recommendations suggest that genetic testing for conditions like Prader-Willi syndrome can be beneficial following an autism diagnosis in childhood, due to the higher rates of co-occurrence.

Autistic Burnout

Characterized by exhaustion from masking autistic traits and coping with daily demands, autistic burnout can significantly affect mental health and resembles the fatigue seen in chronic fatigue syndrome.

ARFID or History of "Eating Disorder"

ARFID, or Avoidant/Restrictive Food Intake Disorder, is characterized by a limited range of food choices stemming from:

  • Avoidance of specific sensory characteristics in food, such as textures or smells.

  • Aversions to certain foods or the feeding environment, often as a trauma response to prior experiences like choking, force-feeding, or pain.

  • Restrictions due to low appetite, disinterest, or a lack of enjoyment in food.

Many Autistic individuals across all age groups may experience ARFID or have a history of eating challenges. These challenges are often misinterpreted as other eating disorders, like Anorexia Nervosa, or simply dismissed as “picky eating.” These feeding issues can contribute to or be caused by gastrointestinal (GI) problems, interoceptive difficulties, and can exacerbate nutritional deficiencies or other health conditions (Schmidt et al, 2021).

Although current research suggests a prevalence rate of ARFID in Autistic individuals at around 16%, this figure is likely a conservative estimate. Clinical experience indicates that this number is probably much higher. ARFID has only been formally recognized since the publication of DSM-5 in 2013 and is still predominantly considered a pediatric condition. However, a broader understanding acknowledges that ARFID affects individuals of all ages. For many undiagnosed Autistic individuals, feeding behaviors may represent their initial interaction with the medical system. Further exploration of these issues will be discussed in our upcoming blog post on Gut Health, ARFID, and sensory eating.

Alexithymia

Alexithymia, characterized by difficulties in recognizing and expressing emotions, is notably more prevalent in the Autistic community. Estimates suggest that approximately 50% of Autistic individuals experience alexithymia. This condition is not only about emotional recognition and expression but also has broader implications for overall health. Alexithymia is associated with an increased incidence of chronic pain, burnout, somatization, and other chronic health conditions (Aron, 2019; Kojima, 2012).

Significant Sensory Issues/SPDs (Sensory Processing Differences)

Sensory processing differences are indeed a defining characteristic of autism. Many Autistic individuals experience either heightened or diminished sensitivities to various sensory inputs, such as light, sound, touch, or taste. Additionally, differences in interoception, the internal perception of bodily sensations, are common, with some experiencing reduced awareness or an amplification of internal signals. 

These sensory processing differences play a crucial role in shaping the daily experiences of Autistic people, profoundly impacting their interaction with health and illness. Such sensitivities can extend to gastrointestinal discomforts, influencing eating habits and potentially leading to issues like ARFID. Moreover, heightened or altered sensory perceptions can also affect hydration, as the sensory qualities of liquids might be challenging for some. These nuances in sensory processing are not just isolated experiences; they directly contribute to the overall management and navigation of various health conditions, underscoring the need for tailored approaches in healthcare and daily living strategies.

While it's true that sensory processing sensitivities can develop in anyone undergoing chronic illness, for Autistic individuals, these sensitivities are typically present from childhood. They constitute a core part of their baseline experience. Notably, these sensitivities may intensify during periods of Autistic burnout or when facing additional health challenges.

Language and Auditory Processing Differences

Autistic people often exhibit distinct language and auditory processing differences. These differences can result in challenges with typical (allistic) communication styles. Autistic brains generally process information in a bottom-up, detail-oriented manner. This means that Autistic individuals might process their environments and information more deeply, and sometimes more slowly, compared to non-autistic individuals.

This bottom-up processing style and distinct approach to language and communication are key factors that distinguish autism from CFS/ME and other conditions primarily affecting the nervous system. The unique nature of Autistic communication has been observed in the way Autistic people often relate more naturally with each other. This distinctive communication style and mutual understanding amongst Autistic individuals can be considered a cultural difference, reflecting a shared experience and perspective within the Autistic community (Crompton et al., 2020

Distinct Autistic Brain Style

Similarly, the Autistic brain style is distinctly its own, characterized by a distinct way of processing information and perceiving the world. This distinctive approach influences various aspects of life for Autistic individuals, from how they engage in social interactions to their methods of problem-solving, to self-soothing through routine and repetition. This is also a distinguishing feature from other nervous-system based conditions such as Chronic Fatigue Syndrome. 

Present from Birth

Finally, a critical distinguishing factor of autism lies in its etiology. Autism is a neurotype that is inherently present from birth, deeply embedded in an individual's neurological framework. This innate aspect sets it apart from conditions like CFS/ME, which typically develop later in life. Understanding autism as an intrinsic part of an individual's neurology from the outset is essential, as it underscores the fundamental differences between autism and other conditions that emerge over time.

continued in part 2


References

Aaron RV, Fisher EA, de la Vega R, Lumley MA, Palermo TM. Alexithymia in individuals with chronic pain and its relation to pain intensity, physical interference, depression, and anxiety: a systematic review and meta-analysis. Pain. 2019 May;160(5):994-1006. doi: 10.1097/j.pain.0000000000001487. PMID: 31009416; PMCID: PMC6688175.

Afari, N., & Buchwald, D. (2003). Chronic fatigue syndrome: a review. American Journal of Psychiatry, 160(2), 221-236.

Aronica L, Ordovas JM, Volkov A, Lamb JJ, Stone PM, Minich D, Leary M, Class M, Metti D, Larson IA, Contractor N, Eck B, Bland JS. Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine. Nutrients. 2022 Feb 11;14(4):768. doi: 10.3390/nu14040768. PMID: 35215417; PMCID: PMC8876337.

Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am J Med. 1959 Apr;26(4):569-95. doi: 10.1016/0002-9343(59)90280-3. PMID: 13637100.

Atchison CJ, Davies B, Cooper E, Lound A, Whitaker M, Hampshire A, Azor A, Donnelly CA, Chadeau-Hyam M, Cooke GS, Ward H, Elliott P. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat Commun. 2023 Oct 24;14(1):6588. doi: 10.1038/s41467-023-41879-2. PMID: 37875536; PMCID: PMC10598213.

Bennett JA, Germani T, Haqq AM, Zwaigenbaum L. Autism spectrum disorder in Prader-Willi syndrome: A systematic review. Am J Med Genet A. 2015 Dec;167A(12):2936-44. doi: 10.1002/ajmg.a.37286. Epub 2015 Aug 29. PMID: 26331980.

Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223-49. doi: 10.1515/reveh-2015-0026. PMID: 26613325.

Booth NE, Myhill S, McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Int J Clin Exp Med. 2012;5(3):208-20. Epub 2012 Jun 15. PMID: 22837795; PMCID: PMC3403556.

Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol. 2016 Oct 15;594(20):5781-5790. doi: 10.1113/JP271539. Epub 2016 May 1. PMID: 27059884; PMCID: PMC5063949.

Bonaz B, Lane RD, Oshinsky ML, Kenny PJ, Sinha R, Mayer EA, Critchley HD. Diseases, Disorders, and Comorbidities of Interoception. Trends Neurosci. 2021 Jan;44(1):39-51. doi: 10.1016/j.tins.2020.09.009. PMID: 33378656.

Bonaz B, Sinniger V, Pellissier S. The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol. 2017 Nov 2;8:1452. doi: 10.3389/fimmu.2017.01452. PMID: 29163522; PMCID: PMC5673632.

Brewer JH, Thrasher JD, Straus DC, Madison RA, Hooper D. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins (Basel). 2013 Apr 11;5(4):605-17. doi: 10.3390/toxins5040605. PMID: 23580077; PMCID: PMC3705282.

Buckley L, MacHale SM, Cavanagh JT, Sharpe M, Deary IJ, Lawrie SM. Personality dimensions in chronic fatigue syndrome and depression. J Psychosom Res. 1999 Apr;46(4):395-400. doi: 10.1016/s0022-3999(98)00120-2. PMID: 10340240.

Chao LL, Kriger S, Buckley S, Ng P, Mueller SG. Effects of low-level sarin and cyclosarin exposure on hippocampal subfields in Gulf War Veterans. Neurotoxicology. 2014 Sep;44:263-9. doi: 10.1016/j.neuro.2014.07.003. Epub 2014 Jul 21. PMID: 25058901; PMCID: PMC5464327.

Chu, L., Valencia, I. J., Garvert, D. W., & Montoya, J. G. (2019). Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in pediatrics, 7, 12.

Crompton, C. J., Sharp, M., Axbey, H., Fletcher-Watson, S., Flynn, E. G., & Ropar, D. (2020). Neurotype-matching, but not being autistic, influences self and observer ratings of interpersonal rapport. Frontiers in Psychology, 11, 2961.

Csecs JLL, Iodice V, Rae CL, Brooke A, Simmons R, Quadt L, Savage GK, Dowell NG, Prowse F, Themelis K, Mathias CJ, Critchley HD, Eccles JA. Joint Hypermobility Links Neurodivergence to Dysautonomia and Pain. Front Psychiatry. 2022 Feb 2;12:786916. doi: 10.3389/fpsyt.2021.786916. PMID: 35185636; PMCID: PMC8847158.

Dancey CP, Friend J. Symptoms, impairment and illness intrusiveness--their relationship with depression in women with CFS/ME. Psychol Health. 2008;23(8):983-99. doi: 10.1080/08870440701619957. PMID: 25160923.

Daniels, J., Brigden, A., & Kacorova, A. (2017). Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): examining the incidence of health anxiety in CFS/ME. Psychology and Psychotherapy: Theory, Research and Practice, 90(3), 502-509.

Dargenio VN, Dargenio C, Castellaneta S, De Giacomo A, Laguardia M, Schettini F, Francavilla R, Cristofori F. Intestinal Barrier Dysfunction and Microbiota-Gut-Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder. Nutrients. 2023 Mar 27;15(7):1620. doi: 10.3390/nu15071620. PMID: 37049461; PMCID: PMC10096948.

de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):418-24. doi: 10.1097/MPG.0b013e3181dcc4a5. PMID: 20683204.

Dong H, Zhang X, Qian Y. Mast cells and neuroinflammation. Med Sci Monit Basic Res. 2014 Dec 21;20:200-6. doi: 10.12659/MSMBR.893093. PMID: 25529562; PMCID: PMC4282993.

Eisenlohr-Moul T, Divine M, Schmalenberger K, Murphy L, Buchert B, Wagner-Schuman M, Kania A, Raja S, Miller AB, Barone J, Ross J. Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder. BMC Psychiatry. 2022 Mar 19;22(1):199. doi: 10.1186/s12888-022-03851-0. PMID: 35303811; PMCID: PMC8933886.

Giloteaux, L., Goodrich, J.K., Walters, W.A. et al. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome 4, 30 (2016). 

Gotts ZM, Deary V, Newton J, Van der Dussen D, De Roy P, Ellis JG. Are there sleep-specific phenotypes in patients with chronic fatigue syndrome? A cross-sectional polysomnography analysis. BMJ Open. 2013 Jun 20;3(6):e002999. doi: 10.1136/bmjopen-2013-002999. PMID: 23794547; PMCID: PMC3669720.

Groenman AP, Torenvliet C, Radhoe TA, Agelink van Rentergem JA, Geurts HM. Menstruation and menopause in autistic adults: Periods of importance? Autism. 2022 Aug;26(6):1563-1572. doi: 10.1177/13623613211059721. Epub 2021 Nov 26. PMID: 34825585; PMCID: PMC9344571.

Engineer CT, Hays SA, Kilgard MP. Vagus nerve stimulation as a potential adjuvant to behavioral therapy for autism and other neurodevelopmental disorders. J Neurodev Disord. 2017 Jul 4;9:20. doi: 10.1186/s11689-017-9203-z. PMID: 28690686; PMCID: PMC5496407.

Espinosa P, Urra JM. Decreased Expression of the CD57 Molecule in T Lymphocytes of Patients with Chronic Fatigue Syndrome. Mol Neurobiol. 2019 Sep;56(9):6581-6585. doi: 10.1007/s12035-019-1549-7. Epub 2019 Mar 21. PMID: 30895436.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013. PMID: 21376230.

Heim C, Wagner D, Maloney E, Papanicolaou DA, Solomon L, Jones JF, Unger ER, Reeves WC. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry. 2006 Nov;63(11):1258-66. doi: 10.1001/archpsyc.63.11.1258. PMID: 17088506. 

Heim C, Nater UM, Maloney E, Boneva R, Jones JF, Reeves WC. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry. 2009 Jan;66(1):72-80. doi: 10.1001/archgenpsychiatry.2008.508. PMID: 19124690.

Kojima, M. Alexithymia as a prognostic risk factor for health problems: a brief review of epidemiological studies. BioPsychoSocial Med 6, 21 (2012). https://doi.org/10.1186/1751-0759-6-21

Kong, X., Zhu, J., Tian, R., Liu, S., Sherman, H. T., Zhang, X., ... & Wan, G. (2020). Early screening and risk factors of autism spectrum disorder in a large cohort of Chinese patients with Prader-Willi syndrome. Frontiers in psychiatry, 11, 594934.

Kossewska J, Bierlit K, Trajkovski V. Personality, Anxiety, and Stress in Patients with Small Intestine Bacterial Overgrowth Syndrome. The Polish Preliminary Study. Int J Environ Res Public Health. 2022 Dec 21;20(1):93. doi: 10.3390/ijerph20010093. PMID: 36612414; PMCID: PMC9819554.

Lee M, Krishnamurthy J, Susi A, Sullivan C, Gorman GH, Hisle-Gorman E, Erdie-Lalena CR, Nylund CM. Association of Autism Spectrum Disorders and Inflammatory Bowel Disease. J Autism Dev Disord. 2018 May;48(5):1523-1529. doi: 10.1007/s10803-017-3409-5. PMID: 29170940.

Li Y, Qiu S, Shi J, Guo Y, Li Z, Cheng Y, Liu Y. Association between MTHFR C677T/A1298C and susceptibility to autism spectrum disorders: a meta-analysis. BMC Pediatr. 2020 Sep 24;20(1):449. doi: 10.1186/s12887-020-02330-3. PMID: 32972375; PMCID: PMC7517654.

Liu CH, Yang MH, Zhang GZ, Wang XX, Li B, Li M, Woelfer M, Walter M, Wang L. Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression. J Neuroinflammation. 2020 Feb 12;17(1):54. doi: 10.1186/s12974-020-01732-5. PMID: 32050990; PMCID: PMC7017619.

Lievesley K, Rimes KA, Chalder T. A review of the predisposing, precipitating and perpetuating factors in Chronic Fatigue Syndrome in children and adolescents. Clin Psychol Rev. 2014 Apr;34(3):233-48. doi: 10.1016/j.cpr.2014.02.002. Epub 2014 Mar 1. PMID: 24632047.

Maes M, Mihaylova I, De Ruyter M. Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord. 2006 Feb;90(2-3):141-7. doi: 10.1016/j.jad.2005.11.002. Epub 2005 Dec 9. PMID: 16338007.

Maes M, Mihaylova I, Leunis JC. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J Affect Disord. 2007 Apr;99(1-3):237-40. doi: 10.1016/j.jad.2006.08.021. Epub 2006 Sep 27. PMID: 17007934.

Maes M, Leunis JC. Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuro Endocrinol Lett. 2008 Dec;29(6):902-10. PMID: 19112401.

Magnusson AE, Nias DK, White PD. Is perfectionism associated with fatigue? J Psychosom Res. 1996 Oct;41(4):377-83. doi: 10.1016/s0022-3999(96)00189-4. PMID: 8971668.

Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007 May;85(5):1185-96. doi: 10.1093/ajcn/85.5.1185. PMID: 17490952.

Makris G, Agorastos A, Chrousos GP, Pervanidou P. Stress System Activation in Children and Adolescents With Autism Spectrum Disorder. Front Neurosci. 2022 Jan 13;15:756628. doi: 10.3389/fnins.2021.756628. PMID: 35095389; PMCID: PMC8793840.

Mallorquí-Bagué N, Garfinkel SN, Engels M, Eccles JA, Pailhez G, Bulbena A, Critchley HD. Neuroimaging and psychophysiological investigation of the link between anxiety, enhanced affective reactivity and interoception in people with joint hypermobility. Front Psychol. 2014 Oct 14;5:1162. doi: 10.3389/fpsyg.2014.01162. PMID: 25352818; PMCID: PMC4196473

McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014 May;133(5):872-83. doi: 10.1542/peds.2013-3995. PMID: 24777214.

McGinnis WR, Audhya T, Walsh WJ, Jackson JA, McLaren-Howard J, Lewis A, Lauda PH, Bibus DM, Jurnak F, Lietha R, Hoffer A. Discerning the Mauve Factor, Part 1. Altern Ther Health Med. 2008 Mar-Apr;14(2):40-50. Erratum in: Altern Ther Health Med. 2008 May-Jun;14(3):15. PMID: 18383989.

McGinnis WR, Audhya T, Walsh WJ, Jackson JA, McLaren-Howard J, Lewis A, Lauda PH, Bibus DM, Jurnak F, Lietha R, Hoffer A. Discerning the Mauve factor, Part 2. Altern Ther Health Med. 2008 May-Jun;14(3):56-62. PMID: 18517107.

Monzio Compagnoni G, Di Fonzo A, Corti S, Comi GP, Bresolin N, Masliah E. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease. Mol Neurobiol. 2020 Jul;57(7):2959-2980. doi: 10.1007/s12035-020-01926-1. Epub 2020 May 22. PMID: 32445085; PMCID: PMC9047992.

Morris G, Berk M, Walder K, Maes M. The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability. Mol Neurobiol. 2016 May;53(4):2550-71. doi: 10.1007/s12035-015-9262-7. Epub 2015 Jun 17. PMID: 26081141.

Nakanishi G, Pita-Oliveira M, Bertagnolli LS, Torres-Loureiro S, Scudeler MM, Cirino HS, Chaves ML, Miwa B, Rodrigues-Soares F. Worldwide Systematic Review of GSTM1 and GSTT1 Null Genotypes by Continent, Ethnicity, and Therapeutic Area. OMICS. 2022 Oct;26(10):528-541. doi: 10.1089/omi.2022.0090. Epub 2022 Sep 16. PMID: 36112350.

Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2016 Sep;44(5):447-59. doi: 10.1111/apt.13706. Epub 2016 Jul 11. PMID: 27397586.

Poznyak AV, Ivanova EA, Sobenin IA, Yet SF, Orekhov AN. The Role of Mitochondria in Cardiovascular Diseases. Biology (Basel). 2020 Jun 25;9(6):137. doi: 10.3390/biology9060137. PMID: 32630516; PMCID: PMC7344641.

Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, Scheibenbogen C, Murovska M, Prusty BK; European Network on ME/CFS (EUROMENE). Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2018 Oct 1;16(1):268. doi: 10.1186/s12967-018-1644-y. PMID: 30285773; PMCID: PMC6167797.

Rauch SAM, King A, Kim HM, Powell C, Rajaram N, Venners M, Simon NM, Hamner M, Liberzon I. Cortisol awakening response in PTSD treatment: Predictor or mechanism of change. Psychoneuroendocrinology. 2020 Aug;118:104714. doi: 10.1016/j.psyneuen.2020.104714. Epub 2020 May 15. PMID: 32446108; PMCID: PMC7984524.

Reynolds, A. M., Soke, G. N., Sabourin, K. R., Hepburn, S., Katz, T., Wiggins, L. D., Schieve, L. A., & Levy, S. E. (2019). Sleep Problems in 2- to 5-Year-Olds With Autism Spectrum Disorder and Other Developmental Delays. Pediatrics, 143(3), e20180492. https://doi.org/10.1542/peds.2018-0492

Sandin S, Lichtenstein P, Kuja-Halkola R, Hultman C, Larsson H, Reichenberg A. The Heritability of Autism Spectrum Disorder. JAMA. 2017 Sep 26;318(12):1182-1184. doi: 10.1001/jama.2017.12141. PMID: 28973605; PMCID: PMC5818813.

Sharp HEC, Critchley HD, Eccles JA. Connecting brain and body: Transdiagnostic relevance of connective tissue variants to neuropsychiatric symptom expression. World J Psychiatry. 2021 Oct 19;11(10):805-820. doi: 10.5498/wjp.v11.i10.805. PMID: 34733643; PMCID: PMC8546774.

Schmidt R, Hiemisch A, Kiess W, von Klitzing K, Schlensog-Schuster F, Hilbert A. Macro- and Micronutrient Intake in Children with Avoidant/Restrictive Food Intake Disorder. Nutrients. 2021 Jan 27;13(2):400. doi: 10.3390/nu13020400. PMID: 33513954; PMCID: PMC7911718.

Shoemaker RC, House D, Ryan JC. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant®. Neurotoxicol Teratol. 2014 Sep-Oct;45:18-26. doi: 10.1016/j.ntt.2014.06.004. Epub 2014 Jun 17. PMID: 24946038.

Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, Scheibenbogen C; European Network on ME/CFS (EUROMENE). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease. Autoimmun Rev. 2018 Jun;17(6):601-609. doi: 10.1016/ j.autrev.2018.01.009. Epub 2018 Apr 7. PMID: 29635081. 

Springer A, Oleksa-Marewska K, Basińska-Zych A, Werner I, Białowąs S. Occupational burnout and chronic fatigue in the work of academic teachers-moderating role of selected health behaviours. PLoS One. 2023 Jan 26;18(1):e0280080. doi: 10.1371/journal.pone.0280080. PMID: 36701360; PMCID: PMC9879519. 

Szyf M. The epigenetics of early life adversity and trauma inheritance: an interview with Moshe Szyf. Epigenomics. 2022 Mar;14(6):309-314. doi: 10.2217/epi-2021-0483. Epub 2021 Dec 8. PMID: 34877868.

Theoharides TC, Kavalioti M, Tsilioni I. Mast Cells, Stress, Fear and Autism Spectrum Disorder. Int J Mol Sci. 2019 Jul 24;20(15):3611. doi: 10.3390/ijms20153611. PMID: 31344805; PMCID: PMC6696098.

Tomas C, Newton J, Watson S. A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. ISRN Neurosci. 2013 Sep 30;2013:784520. doi: 10.1155/2013/784520. PMID: 24959566; PMCID: PMC4045534.

Traianos E, Dibnah B, Lendrem D, et alAB0051 THE EFFECTS OF NON-INVASIVE VAGUS NERVE STIMULATION ON IMMUNOLOGICAL RESPONSES AND PATIENT REPORTED OUTCOME MEASURES OF FATIGUE IN PATIENTS WITH CHRONIC FATIGUE SYNDROME, FIBROMYALGIA, AND RHEUMATOID ARTHRITISAnnals of the Rheumatic Diseases 2021;80:1057-1058.

Tsai SY, Chen HJ, Lio CF, Kuo CF, Kao AC, Wang WS, Yao WC, Chen C, Yang TY. Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study. J Transl Med. 2019 Feb 22;17(1):55. doi: 10.1186/s12967-019-1797-3. PMID: 30795765; PMCID: PMC6387539.

Tsilioni I, Patel AB, Pantazopoulos H, Berretta S, Conti P, Leeman SE, Theoharides TC. IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin. Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21659-21665. doi: 10.1073/pnas.1906817116. Epub 2019 Oct 7. PMID: 31591201; PMCID: PMC6815178.

van Rensburg R, Meyer HP, Hitchcock SA, Schuler CE. Screening for Adult ADHD in Patients with Fibromyalgia Syndrome. Pain Med. 2018 Sep 1;19(9):1825-1831. doi: 10.1093/pm/pnx275. PMID: 29099955.

Wang SX, Wu WC. Effects of psychological stress on small intestinal motility and bacteria and mucosa in mice. World J Gastroenterol. 2005 Apr 7;11(13):2016-21. doi: 10.3748/wjg.v11.i13.2016. PMID: 15800998; PMCID: PMC4305729.

Wang T, Yin J, Miller AH, Xiao C. A systematic review of the association between fatigue and genetic polymorphisms. Brain Behav Immun. 2017 May;62:230-244. doi: 10.1016/j.bbi.2017.01.007. Epub 2017 Jan 12. PMID: 28089639; PMCID: PMC5947855.

Weiss RB, Stange JP, Boland EM, Black SK, LaBelle DR, Abramson LY, Alloy LB. Kindling of life stress in bipolar disorder: comparison of sensitization and autonomy models. J Abnorm Psychol. 2015 Feb;124(1):4-16. doi: 10.1037/abn0000014. PMID: 25688428; PMCID: PMC4332547.

Wojcik DP, Godfrey ME, Christie D, Haley BE. Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006). Neuro Endocrinol Lett. 2006 Aug;27(4):415-23. PMID: 16891999.

Yang EV, Webster Marketon JI, Chen M, Lo KW, Kim SJ, Glaser R. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression. Brain Behav Immun. 2010 Oct;24(7):1089-96. doi: 10.1016/j.bbi.2010.04.013. Epub 2010 May 11. PMID: 20466055; PMCID: PMC2939213.

Yap CX, Henders AK, Alvares GA, Wood DLA, Krause L, Tyson GW, Restuadi R, Wallace L, McLaren T, Hansell NK, Cleary D, Grove R, Hafekost C, Harun A, Holdsworth H, Jellett R, Khan F, Lawson LP, Leslie J, Frenk ML, Masi A, Mathew NE, Muniandy M, Nothard M, Miller JL, Nunn L, Holtmann G, Strike LT, de Zubicaray GI, Thompson PM, McMahon KL, Wright MJ, Visscher PM, Dawson PA, Dissanayake C, Eapen V, Heussler HS, McRae AF, Whitehouse AJO, Wray NR, Gratten J. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell. 2021 Nov 24;184(24):5916-5931.e17. doi: 10.1016/j.cell.2021.10.015. Epub 2021 Nov 11. PMID: 34767757.

Yuzefovych LV, Pastukh VM, Ruchko MV, Simmons JD, Richards WO, Rachek LI. Plasma mitochondrial DNA is elevated in obese type 2 diabetes mellitus patients and correlates positively with insulin resistance. PLoS One. 2019 Oct 10;14(10):e0222278. doi: 10.1371/journal.pone.0222278. PMID: 31600210; PMCID: PMC6786592.